News updates from the JAAD family of journals

• Congratulations to JAAD

• JAAD Case Reports Welcomes Abby S. Van Voorhees, MD, as Editor

• JAAD International Indexed in the Web of Science!

• Announcing JAAD Reviews! A new journal from the JAAD Family of Journals

• Shari R. Lipner MD, PhD is the Inaugural Editor-in-Chief of JAAD Reviews!

• Congratulations to Dr. Grant-Kels on Clarence S. Livingood, MD Award and Lectureship

• Case reports prompt CDC investigation of possible treatment-resistant dermatophytosis

• Congratulations and Welcome to Dr. Julia Riley, JAAD Case Reports New Skin of Color Special Editor

• JAAD Skin of Color Image Collection and Atlas

• Digital Health in Dermatology

• COVID-19 and the Skin

Congratulations to the Journal of the American Academy of Dermatology!

For the fifth year in a row JAAD holds the #1 Impact Factor in the Dermatology category with a 2023 IF of 12.8!

Abby S. Van Voorhees, MD, will assume the role of Editor of JAAD Case Reports (JDCR), beginning June 1, 2024. Dr. Van Voorhees is currently Professor and Chair at Eastern (Norfolk) Virginia Medical School. Her AAD involvement is extensive, including service on the JAAD Editorial Board, as Physician Editor of Dermatology World (2011-2018), and as a member of the AAD Board of Directors (2018-2022). Dr. Van Voorhees is a psoriasis expert and active in the National Psoriasis Foundation. She has authored many peer-reviewed publications. A well-respected educator, Dr. Van Voorhees is excited to guide Case Reports into the future. “I am particularly interested in working with case reports and case series because they are so truly valued by the practicing dermatologist, often providing guidance for the trickiest patients that we handle,” she said.

The American Academy of Dermatology and Elsevier are delighted to announce that JAAD International (JAADi) opens in new tab/window has been selected for indexing in the Emerging Sources Citation Index opens in new tab/window (ESCI) by Clarivate's Web of Science. The Journal is expected to receive its first Impact Factor in 2025. Thanks to the journal’s editorial team, reviewers and authors who have contributed to the success of this popular open access journal. The JAAD Editors look forward to working with all to build on this success and take JAADi to the next level of excellence. Note that the journal’s anticipated 2023 CiteScore is 3.6.

JAAD Reviews opens in new tab/window is one of three open access companion titles to the highly-respected Journal of The American Academy of Dermatology (JAAD). opens in new tab/window

JAAD Reviews opens in new tab/window seeks high quality, clinical reviews, systematic reviews, scoping reviews, and meta-analyses that support the mission of JAAD opens in new tab/window. JAAD Reviews opens in new tab/window will consider review articles that advance dermatological expertise by publishing evidence-based research to help dermatologists improve patient outcomes.

Shari R. Lipner MD, PhD is the new Editor-in-Chief of JAAD Reviews, a new open access journal from the JAAD Family of Journals. Dr. Lipner previously served as the VisualDx nail editor, where she developed and edited the nail disease content and helped to curate representative images for nail conditions including a range of skin types. She has also edited the dermatology content for Dynamed, which provides up-to-date evidenced based information to physicians of different specialties.

Dr. Lipner has served for many years on Dialogues in Dermatology, conducting interviews with dermatologists on various topics and editing content. Having worked on the AAD Public Education Committee for many years, and served as chair of the committee, she was responsible for editing print and web-based content.

JAAD Deputy Editor Jane Grant-Kels, MD, FAAD, professor of dermatology, pathology, and pediatrics, and director of the Cutaneous Oncology Center and Melanoma Program at the University of Connecticut, delivered the Clarence S. Livingood, MD Award and Lectureship during the Plenary Session at the 2023 AAD Annual Meeting in New Orleans on March 19.

Speaking on the topic “Ethical Dilemmas Hiding in Plain Site opens in new tab/window”, Dr. Grant-Kels explored the importance of ethics and the nuanced boundaries of ethical behavior in the practice of dermatology.

To read more about the substance of this lecture, and other news from the 2023 AAD Annual Meeting, visit the DermWorld Meeting News Central website opens in new tab/window.

Responding to JAAD Case Reports articles indicating a growing problem, the United States Centers for Disease Control and Prevention (CDC) is investigating whether a pattern of treatment-resistant dermatophytosis is emerging.

The CDC asks dermatologists who see patients with tinea infections to complete its survey so it can assess the extent of this problem.

Gu, David et al reported what they believed to be the first U.S. case of treatment-resistant dermatophytosis in a 2020 JAAD Case Reports article. A response in 2022 suggested a second case had been identified. The literature indicates that treatment resistance has been seen in India and possibly elsewhere.

Dr. Julia Riley is an Assistant Professor of Dermatology at Feinberg School of Medicine. Dr. Riley completed her residency at Northwestern in 2020 before joining the faculty. At Northwestern, she serves as the Assistant Director of the Center for Ethnic Skin & Hair and the Director of the HS Clinic. She also serves as the Dermatology Clerkship Director and the Co-Chair of the Department of Dermatology’s Diversity and Inclusion Committee. Her clinical interests include Skin of Color, spanning from pigmentary disorders to hair disorders, as well as Hidradenitis Suppurativa. Her research interests include disparities in Hidradenitis Suppurativa as well as education of residents, medical students and other health care providers on the diagnosis and management of dermatologic conditions in patients of color. Additionally, Dr. Riley is pursuing a master’s degree in health services and outcomes research.